Patents by Inventor Branson CHEN

Branson CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10517937
    Abstract: Methods for the treatment of cancer using double negative (DN) T cells are described. The DNTs may be used for the treatment of chemotherapy-resistant cancers such as recurring or relapsing acute myeloid leukemia (AML). The use of allogenic DNTs, such as those derived from healthy donors, that do not exhibit toxicity towards normal host tissues and the complications associated with graft-versus-host-disease, is also described.
    Type: Grant
    Filed: August 17, 2015
    Date of Patent: December 31, 2019
    Assignee: University Health Network
    Inventors: Li Zhang, Jong Bok Lee, Branson Chen
  • Publication number: 20170274060
    Abstract: Methods for the treatment of cancer using double negative (DN) T cells are described. The DNTs may be used for the treatment of chemotherapy-resistant cancers such as recurring or relapsing acute myeloid leukemia (AML). The use of allogenic DNTs, such as those derived from healthy donors, that do not exhibit toxicity towards normal host tissues and the complications associated with graft-versus-host-disease, is also described.
    Type: Application
    Filed: August 17, 2015
    Publication date: September 28, 2017
    Inventors: Li ZHANG, Jong Bok LEE, Branson CHEN